WINNIPEG, MANITOBA--(MARKET WIRE)--Jun 18, 2007 -- Kane Biotech Inc. (CDNX:KNE.V - News), a biotechnology company engaged in the development of products that prevent and disperse microbial biofilms, is pleased to announce an independent research publication on the Company’s DispersinB technology, a patent pending anti-biofilm technology. The paper appeared in the recent edition of online scientific journal ‘Antimicrobial Agents and Chemotherapy’ published by American Society for Microbiology.
